November 22, 2024
Bulletin interne de l'Institut Pasteur
To mark World Antimicrobial Resistance Awareness Week, which runs from Monday November 18 until today, Friday November 22, the Institut Pasteur wanted to take the opportunity to shine a light on this major public health challenge that is a global cause for concern.
• Highlighting a major health problem: focus on "A tale of resistance"
In 2019, antibiotic-resistant bacteria alone were responsible for 1.3 million deaths. Although antibiotic resistance grabs all the headlines, the problem is much broader: every category of drugs used to prevent and treat infections in humans, animals and even plants – including antivirals, antifungals and antiparasitics – is facing growing resistance.
Find out more
Read the article "A tale of resistance" in the Research Journal
• An international symposium to bring together international experts in the combat against antimicrobials
As final event of the AMR research priority of the Institut Pasteur and with to the support of the Executive Scientific Division / SPAIS, Labex IBEID and the Société de Chimie Thérapeutique, Institut Pasteur and Microb’UP are organizing an international symposium entitled « Tackling antibacterial and antifungal resistant infections from disease to innovative therapies ».
This event, opened by Yasmine Belkaid, will be held on December 9-10, 2024 in the Duclaux amphitheater.
This symposium, open to external participants, aims to bring together multidisciplinary experts to foster collaboration and translational research, and to promote innovative approaches to tackle antibiotic- and antifungal-resistant infections. Internationally renowned experts, researchers and clinicians will share their latest advances in this field, covering topics such as epidemiological surveillance, resistance mechanisms, the discovery of new antibiotics and antifungals, and innovative approaches to combating these infections.
This one-and-a-half-day symposium (December 9th at 2pm until December 10th, 2024 at 5.30pm) will be organized around 4 sessions:
• Treatment escape and AMR in patients and animals
• Mechanisms of resistance and treatment escape
• Chemistry for new treatments
• Natural products and novel therapeutic strategies
The event will include keynotes presentations, oral communications from submitted abstracts, a poster session and selected short-talks from the posters.
To view the full program, click here
Scientific & Organization Commitee
Institut Pasteur (France): Paola B. Arimondo, Emilie Boutet, Iuliana Ene, Philippe Glaser
Université Paris Cité/Hôpital Bichat (France): Laurence Armand-Lefèvre
Helmholtz Institute for Pharmaceutical Research Saarland (Germany): Rolf Müller
University of Oxford (England): Chris Schofield
EMBL (Germany): Athanasios Typas
Contact & Information
For any question, please feel free to contact Emilie Boutet: emilie.boutet@pasteur.fr